Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neogenomics Inc Issues Q4 2013 Guidance; Revenue Guidance Above Analysts' Estimates; Raises FY 2013 Revenue Guidance; Raises Low End Of Prior FY 2013 EPS Guidance


Wednesday, 23 Oct 2013 07:00am EDT 

Neogenomics Inc announced that it expect revenue of $17.6-$18.1 million and earnings of $0.01 to $0.02 per share in the fourth quarter of 2013. For fiscal 2013, the Company expect revenue to be $65.7-$66.2 million with earnings per share of $0.03 to $0.04. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $17.4 million and EPS of $0.01 for the fourth quarter of 2013; and revenue of $65.6 million and EPS of $0.03 for fiscal 2013. 

Company Quote

5.39
0.21 +4.05%
25 Jul 2014